Osaic Holdings
HQL

Osaic Holdings’s abrdn Life Sciences Investors HQL Stock Holding History

Osaic Holdings’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$913K Buy
45,601
+8,909
+24% +$157K ﹤0.01% 3098
2026
Q1 		$597K Sell
36,692
-1,289
-3% -$21.5K ﹤0.01% 3178
2025
Q4 		$637K Buy
37,981
+4,966
+15% +$83.4K ﹤0.01% 3119
2025
Q3 		$480K Buy
33,015
+2,556
+8% +$35K ﹤0.01% 3457
2025
Q2 		$390K Buy
30,459
+6,802
+29% +$83.9K ﹤0.01% 3362
2025
Q1 		$300K Buy
23,657
+8,959
+61% +$121K ﹤0.01% 3295
2024
Q4 		$193K Sell
14,698
-68
-0.5% -$981 ﹤0.01% 3632
2024
Q3 		$223K Buy
14,766
+274
+2% +$4.15K ﹤0.01% 3563
2024
Q2 		$205K Sell
14,492
-61,151
-81% -$827K ﹤0.01% 3535
2024
Q1 		$1.03M Buy
75,643
+2,612
+4% +$36.1K ﹤0.01% 2299
2023
Q4 		$983K Sell
73,031
-11,452
-14% -$141K ﹤0.01% 2522
2023
Q3 		$1.05M Buy
84,483
+8,443
+11% +$111K ﹤0.01% 2592
2023
Q2 		$1.03M Buy
76,040
+1,271
+2% +$17.5K ﹤0.01% 2495
2023
Q1 		$1.04M Buy
74,769
+3,986
+6% +$57K ﹤0.01% 2424
2022
Q4 		$1.01M Buy
70,783
+3,735
+6% +$54.1K ﹤0.01% 2357
2022
Q3 		$917K Buy
67,048
+267
+0.4% +$3.99K ﹤0.01% 2317
2022
Q2 		$951K Sell
66,781
-2,164
-3% -$32.7K ﹤0.01% 2320
2022
Q1 		$1.14M Sell
68,945
-15,094
-18% -$260K ﹤0.01% 2448
2021
Q4 		$1.62M Sell
84,039
-50,856
-38% -$1.02M ﹤0.01% 1962
2021
Q3 		$2.8M Buy
134,895
+1,409
+1% +$30.2K 0.01% 1450
2021
Q2 		$2.86M Sell
133,486
-3,288
-2% -$66.4K 0.01% 1432
2021
Q1 		$2.69M Buy
136,774
+2,478
+2% +$51.1K 0.01% 1373
2020
Q4 		$2.65M Buy
134,296
+503
+0.4% +$9.3K 0.01% 1237
2020
Q3 		$2.35M Buy
133,793
+9,285
+7% +$166K 0.01% 1207
2020
Q2 		$2.23M Buy
124,508
+10,956
+10% +$188K 0.01% 1196
2020
Q1 		$1.7M Buy
+113,552
New +$1.86M 0.01% 1165

Other funds holding HQL

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
NIM
Needham Investment Management New York $3.33B AUM 163.16% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.56B AUM 35.09% 1-Year Est. Return
1WA
180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return

Osaic Holdings's HQL Position: Q2 2026 in Review

Osaic Holdings increased its abrdn Life Sciences Investors (HQL) stake by 24% in Q2 2026, buying an estimated $157K and bringing the position to 45,601 shares worth $913K. The position accounts for ﹤0.01% of the portfolio, ranked #3098.

Osaic Holdings first reported a position in HQL in Q1 2020 and has held it in 26 quarters since. The position peaked at $2.86M in Q2 2021. 83 funds tracked by Wall St. Rank hold HQL as of Q2 2026.

  • Osaic Holdings held 45,601 shares of abrdn Life Sciences Investors worth $913K as of Q2 2026.
  • Osaic Holdings bought 8,909 abrdn Life Sciences Investors shares in Q2 2026, an estimated $157K.
  • abrdn Life Sciences Investors made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #3098 holding.
  • Osaic Holdings first reported a position in abrdn Life Sciences Investors in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's abrdn Life Sciences Investors position peaked at $2.86M in Q2 2021.
  • 83 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.